Omega Healthcare Investors (NYSE:OHI) Stock Gets Price Target Reduction from UBS Group

Omega Healthcare Investors (NYSE:OHI) had its price target decreased by UBS Group from $54.00 to $52.00 in a report issued on Tuesday,Benzinga reports. UBS Group currently has a buy rating on the real estate investment trust’s stock.

A number of other research analysts have also recently commented on OHI. Weiss Ratings reiterated a “buy (b+)” rating on shares of Omega Healthcare Investors in a research note on Friday, September 25th. Citigroup raised their price objective on Omega Healthcare Investors from $52.00 to $58.00 and gave the company a “buy” rating in a report on Tuesday, August 4th. Raymond James Financial restated an “outperform” rating and set a $53.00 price objective on shares of Omega Healthcare Investors in a research report on Tuesday, October 6th. Cantor Fitzgerald boosted their price objective on Omega Healthcare Investors from $52.00 to $56.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Finally, Wells Fargo & Company lowered their target price on Omega Healthcare Investors from $49.00 to $48.00 and set an “equal weight” rating for the company in a report on Tuesday, September 1st. Six research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Omega Healthcare Investors currently has a consensus rating of “Hold” and a consensus target price of $49.93.

Omega Healthcare Investors Trading Up 0.9%

Shares of Omega Healthcare Investors stock opened at $45.51 on Tuesday. The firm has a market capitalization of $13.79 billion, a PE ratio of 16.25, a price-to-earnings-growth ratio of 1.82 and a beta of 0.53. The firm’s 50 day moving average is $46.30 and its 200 day moving average is $46.92. Omega Healthcare Investors has a 1 year low of $39.26 and a 1 year high of $52.39.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.68. The business had revenue of $328.25 million during the quarter, compared to analysts’ expectations of $266.97 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The firm’s quarterly revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, research analysts anticipate that Omega Healthcare Investors will post 3.12 earnings per share for the current year.

Omega Healthcare Investors Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, August 3rd were issued a dividend of $0.68 per share. This represents a $2.72 dividend on an annualized basis and a yield of 6.0%. The ex-dividend date of this dividend was Monday, August 3rd. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.67. Omega Healthcare Investors’s payout ratio is presently 97.14%.

Hedge Funds Weigh In On Omega Healthcare Investors

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Amundi raised its position in Omega Healthcare Investors by 100.4% during the 2nd quarter. Amundi now owns 1,125,875 shares of the real estate investment trust’s stock worth $53,682,000 after purchasing an additional 564,175 shares during the last quarter. Oxbow Advisors LLC acquired a new position in Omega Healthcare Investors during the 1st quarter worth about $7,373,000. Y Intercept Hong Kong Ltd lifted its holdings in Omega Healthcare Investors by 351.4% during the 1st quarter. Y Intercept Hong Kong Ltd now owns 42,368 shares of the real estate investment trust’s stock worth $1,857,000 after buying an additional 32,982 shares during the period. AlphaGrep UK Ltd acquired a new position in Omega Healthcare Investors during the 2nd quarter worth about $1,246,000. Finally, Greenland Capital Management LP bought a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at about $7,867,000. 65.25% of the stock is currently owned by institutional investors and hedge funds.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) focused on healthcare facilities, with an emphasis on skilled nursing and assisted living properties. The company owns or invests in healthcare real estate and leases its properties to operators that provide care and related services to residents.

Omega generally uses long-term, predominantly triple-net lease arrangements, under which tenants are responsible for many property-level expenses, including maintenance, insurance and taxes.